A research team led by Dr. Sheng Nengyin of the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences has reframed ZC4H2-associated rare disorder (ZARD)—a disorder marked by ...
Comparative analysis of gene expression in embryonic legs and larval wings of the butterfly Bicyclus anynana reveals evidence ...
Tech Times on MSN
Novartis confirms Zolgensma caused tumors in two children via gene therapy vector integration
Novartis confirms Zolgensma's viral vector caused tumors in two children via DNA integration - but the FDA label still calls the risk 'theoretical.' ...
Three people with epilepsy resistant to drug treatment saw the number of seizures they had per month fall by more than 90%, ...
Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, Zolgensma.
Single-cell profiling of nearly 2,000 people brings scientists closer to understanding the link between genetic variation, gene expression and health.
A single gene-editing treatment could someday protect against heart disease, high cholesterol, and other common conditions ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies ...
Autism’s striking sex difference has long presented researchers with a puzzle. Why are boys diagnosed around three to four ...
Reliable capsid titer measurement is one of the most critical analytical requirements in AAV gene therapy development. However, moving a titer assay from development to a GMP-regulated quality control ...
Specific Biologics, a biotechnology company developing precision gene-editing therapies, has completed an oversubscribed $35 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results